SpyGlass Pharma, Inc. (SGP) IPO — S-1 Filing, Stock & Insider Activity

SpyGlass Pharma, Inc. IPO — Status & S-1 Filing

Ticker: SGP
Status: Priced — IPO complete
S-1 filed: 2026-01-16
Effective: 2026-01-30
IPO / pricing date: 2026-02-06
Exchange: NASDAQ
Offering price: $16.00
Shares offered: 9,375,000
SEC CIK: 0001778922 · View the S-1 on SEC EDGAR →

SpyGlass Pharma, Inc. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.

Track every registration update on the InsiderAlpha IPO tracker.

Updated Jul 16, 2026 · Last SEC filing 2026-02-11

SpyGlass Pharma, Inc. (SGP) — no SEC Form 4 insider filings recorded in the last 90 days. 1 Form 8-K material event filings were reported by SGP in the last 90 days. InsiderAlpha tracks every SGP SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About SpyGlass Pharma, Inc. (SGP)

SEC CIK	0001778922

90-Day SEC Filing Activity

Form 8-K filings (90d)	1
Latest Form 4 filing	2026-02-11

Recent SGP Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-02-09	Vensana Capital I GP, LLC	Insider	J — Other acquisition / disposition	548.1K	—	—	SEC
2026-02-09	Vensana Capital I GP, LLC	Insider	J — Other acquisition / disposition	548.1K	—	—	SEC
2026-02-09	Vensana Capital I GP, LLC	Insider	J — Other acquisition / disposition	359.3K	—	—	SEC
2026-02-09	Vensana Capital I GP, LLC	Insider	P — Open-market purchase	165.0K	$16.00	$2.64M	SEC
2026-02-09	Nielsen Kirk G.	Insider	J — Other acquisition / disposition	1.69M	—	—	SEC
2026-02-09	Nielsen Kirk G.	Insider	J — Other acquisition / disposition	548.1K	—	—	SEC
2026-02-09	Nielsen Kirk G.	Insider	J — Other acquisition / disposition	548.1K	—	—	SEC
2026-02-09	Nielsen Kirk G.	Insider	J — Other acquisition / disposition	359.3K	—	—	SEC
2026-02-09	Nielsen Kirk G.	Insider	P — Open-market purchase	165.0K	$16.00	$2.64M	SEC
2026-02-09	BASKETT FOREST	Insider	J — Other acquisition / disposition	1.37M	—	—	SEC
2026-02-09	BASKETT FOREST	Insider	J — Other acquisition / disposition	1.62M	—	—	SEC
2026-02-09	BASKETT FOREST	Insider	J — Other acquisition / disposition	1.37M	—	—	SEC
2026-02-09	BASKETT FOREST	Insider	J — Other acquisition / disposition	738.0K	—	—	SEC
2026-02-09	BASKETT FOREST	Insider	P — Open-market purchase	937.5K	$16.00	$15.00M	SEC
2026-02-09	Vensana Capital I GP, LLC	Insider	J — Other acquisition / disposition	1.69M	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for SpyGlass Pharma, Inc. (SGP). Updated in real time as new filings are submitted to the SEC.

Recent SGP Form 8-K Material Events

2026-05-14 — Item 2.02, 9.01 [SEC]
2026-03-26 — Item 2.02, 9.01 · Earnings · neutral [SEC]
SpyGlass Pharma issued a press release on March 26, 2026 announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025. The filing provides standard financial results reporting without explicit beat/miss or guidance language.
2026-03-09 — Item 8.01, 9.01 · Clinical · positive [SEC]
SpyGlass Pharma announced positive 12-month clinical updates from its Phase 1/2 trial of the Bimatoprost Drug Pad-IOL System, a novel intraocular lens technology. The company released top-line results demonstrating favorable safety and efficacy data, representing a meaningful adv

Recent Insider Filings

2026-02-11 — RA CAPITAL MANAGEMENT, L.P. (Insider)
2026-02-11 — Nielsen Kirk G. (Insider)
2026-02-11 — Behbahani Ali (Insider)
2026-02-11 — Florence Anthony A. Jr. (Insider)
2026-02-11 — BASKETT FOREST (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SGP insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

SGP Insider Trading — FAQ

What is the latest insider trade for SGP?: SpyGlass Pharma, Inc. (SGP) had 0 insider filings in the last 90 days, with the most recent on 2026-02-11. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying SGP stock?: 0 insider purchases of SGP were filed in the last 90 days.
How many insiders are selling SGP stock?: 0 insider sales of SGP were filed in the last 90 days.
Where can I see SGP SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every SGP SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live SGP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.